i
13-valent pneumococcal conjugate vaccine use in children 6 through 18 years of age with immunocompromising conditions : GRADE of evidence
-
February 20, 2013
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +